MENU

First Brexit… then Trump… Now, it’s time for Pro

Is your portfolio really prepared for what’s coming next?

To help investors like you navigate this historically uncertain — yet high-flying — market and prepare for an inevitable downturn, we’re re-opening our Motley Fool Pro Canada service to a select few new members for a short time.

To discover how Pro Canada could help you to increase your upside potential… reduce your downside risk… and earn paycheque-like income in the process, simply click here — before the small number of spots we have left are all gone!

Cameco Corp.: Should Contrarian Investors Buy it Today?

A long slide in the stock price coupled with volatile moves in recent months has some contrarian investors wondering if Cameco Corp. (TSX:CCO)(NYSE:CCJ) is a safe pick.

Let’s take a look at Canada’s top uranium producer to see if it deserves to be in your portfolio.

Rough market

The Fukushima nuclear disaster in 2011 toppled uranium prices and sent the industry into a downturn that continues today.

How bad has it been?

In the days before the tsunami hit Japan, uranium fetched about $70 per pound, and Cameco traded for close to $40 per share.

By late 2016, uranium slipped below US$20 per pound in the spot market, and bargain seekers had a chance to scoop up Cameco for less than $10.

Production cuts and a Trump rally have provided a bit of a lift in recent months. Uranium bounced back above the US$20 mark, and Cameco current trades at $14.50 per share, but the dark days are far from over in the sector.

Cameco recently took a hit when Tokyo Electric Power Company Holdings Inc. (TEPCO) announced that it intends to walk away from a major supply contract.

Management says Cameco plans to fight the decision, but it could result in a loss of $1.3 billion in revenue for cancelled shipments of 9.3 million pounds of uranium through 2028.

Cameco already has plans to reduce production at its facilities this year as it adjusts to the weak market. The TEPCO move is expected to force the company to take an even harder look at its operations, including the potential sale of its U.S. mines.

CRA battle

Cameco is also caught up in a lengthy battle with the Canada Revenue Agency (CRA) over taxes owed on earnings generated through a foreign subsidiary.

If Cameco loses the case, which is currently before the court, it could be on the hook for additional taxes and penalties of more than $2 billion.

That would be a material hit.

A decision in the case isn’t expected until late 2017 at the earliest.

Should you buy?

The long-term outlook for the uranium industry is quite good as countries around the globe push ahead with new plants. Annual uranium demand is expected to increase 50% by 2030.

Tough times over the past six years have resulted in a lack of investment in new production, so a shortage situation could arise in the coming years.

For the moment, however, the ongoing market challenges coupled with the CRA issue are major overhangs on the stock.

If you had the guts to get in at $10, I would consider taking some profits and wait for another pullback to start a new contrarian position.

Six "pro" strategies for today's highly uncertain market

Motley Fool Canada's $250,000-real-money-portfolio service, Motley Fool Pro, is currently closed to new members. But lead advisor Jim Gilles is doing something special for investors who are worried about the market and where it will head in 2017.

He's revealing the six strategies he uses in Pro to help members guardrail their portfolios and make money in up, down, and sideways markets.

For a limited time you can download this "Pro 2017 Survival Guide" free of charge by simply clicking here.

 

Fool contributor Andrew Walker has no position in any stocks mentioned.

NEW! This Stock Could Be Like Buying Amazon In 1997

For only the 5th time in over 14 years, Motley Fool co-founder David Gardner just issued a Buy Recommendation on this recent Canadian IPO.

Stock Advisor Canada’s Chief Investment Adviser, Iain Butler, also recommended this company back in March – and it’s already up a whopping 57%!

Enter your email address below to claim your copy of this brand new report, “Breakthrough IPO Receives Rare Endorsement.”

I consent to receiving information from The Motley Fool via email, direct mail, and occasional special offer phone calls. I understand I can unsubscribe from these updates at any time. Please read the Privacy Statement and Terms of Service for more information.